GlassScriptPhysician profile
Erica Simplice
NPI 1528868668
$2,905.87
in general payments reported to CMS, 2019-2025
18 companies · $2,906 in 2025
The $2,906 reported for 2025 was more than what 96% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $2,906.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,746 · Travel and Lodging: $1,160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,745.98 |
| Travel and Lodging | $1,159.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuronetics, INC. | $1,449.20 | 2025 | Neurostar Tms Therapy System |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $291.18 | 2025 | Caplyta |
| Janssen Pharmaceuticals, INC | $286.11 | 2025 | Invega Sustenna, Spravato |
| Medtronic, INC. | $146.44 | 2025 | Symplicity G3 |
| Axsome Therapeutics, INC. | $145.25 | 2025 | Auvelity |
| Abbvie INC. | $129.79 | 2025 | |
| Almatica Pharma LLC | $95.16 | 2025 | Loreev Xr |
| Vanda Pharmaceuticals INC. | $94.88 | 2025 | Fanapt |
| Neurocrine Biosciences, INC. | $50.23 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $36.46 | 2025 | Trintellix |
| Corium, LLC | $30.66 | 2025 | Azstarys |
| Lilly USA, LLC | $26.46 | 2025 | Kisunla |
| E.R. Squibb & Sons, L.L.C. | $26.23 | 2025 | Cobenfy |
| Bausch Health US, LLC | $21.24 | 2025 | Aplenzin |
| Teva Pharmaceuticals USA, INC. | $20.61 | 2025 | Uzedy |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $20.53 | 2025 | Onyda Xr |
| Alkermes, INC. | $20.52 | 2025 | Lybalvi |
| Lundbeck LLC | $14.92 | 2025 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erica Simplice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.